Monthly Communication Report

Corporation:	AstraZeneca Canada Inc.
Associated registration:	957438-15042-61
Communication date:	2025-10-22
Posted date:	2025-11-15

Designated Public Office Holders who participated in the communication:	Matt Jeneroux, Member of Parliament House of Commons
List of Details Subject matter Detail Economic Development, Health, International Trade, Research and Development, Taxation and Finance Engage with Canadian government officials to discuss and provide input on Canada’s countermeasures and policies in response to foreign tariffs affecting the pharmaceutical industry Intellectual Property, International Trade Patent Act, Patented Medicines (Notice of Compliance) Regulations, Data Protection Regulation, Certificates of Supplementary Protection and related policies regarding the regulation of intellectual property for biopharmaceutical products, and maintaining international competitiveness. Health, International Development, Research and Development Regulations, policies and programs related to the review and reimbursement processes of Health Canada, Canada’s Drug Agency and the pan-Canadian Pharmaceutical Alliance.
Responsible Officer who filed this communication report:	Gaby Bourbara
As the most senior paid officer, the person named above is responsible for certifying the communication report for the corporation or organization (Registrant). This person may or may not have participated in the reported communication. The Lobbyists Registration Regulations do not require that the names of in-house lobbyists (i.e. employees of corporations or organizations) who actually participated in the communication be disclosed.